Skip to content

EPA library

Dermatology

Royal College of Physicians and Surgeons of Canada · 1.0 · 34 EPAs

Also available in French.

Every EPA in the published guide, shown as the form DebriefMD fills in, with its fields and answer options.

Transition to Discipline

  • TTD-1

    Performing patient assessments in the dermatology clinic

    Key features and assessment plan

    - This EPA focuses on the application of clinical skills acquired in medical school in the new setting of dermatology residency. - This includes an appropriate dermatologic history and relevant physical examination, and determining the acuity of the presentation. - It also includes summarizing the findings for oral presentation to a supervisor, demonstrating basic knowledge of skin anatomy and morphology. - At this stage, this EPA does not include developing management plans for the patient’s care.

    Direct observation or case review by supervisor Use Form 1. Form collects information on: - Type of observation: direct; case review Collect 3 observations of achievement - At least 1 direct observation

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Type of observation

    1. direct
    2. case review

    Medical Expert

    • ME 2.2 Elicit an accurate, relevant history
    • ME 2.2 Perform a physical examination that informs the diagnosis
    • ME 2.1 Determine the acuity of the condition
    • ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor

    Communicator

    • COM 1.2 Optimize the physical environment for patient comfort, dignity and privacy
    • COM 2.3 Identify other sources of information (e.g. family, medical record) that may assist in the patient’s care
    • COM 5.1 Document the clinical encounter using a structured approach

    Professional

    • P 1.1 Behave in a professional manner

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

Foundations

  • F-1

    Assessing patients and categorizing conditions of the skin and specialized structures

    Key features and assessment plan

    - The focus of this EPA is assessing, describing, and categorizing common conditions, and proposing a differential and preferred diagnosis. - The skin and specialized structures include the hair, nails, mucous membranes and sweat glands.

    Direct observation or case review with verification of pertinent findings by supervisor or Core or TTP resident Use Form 1. Form collects information on: - Demographic: adult; pediatric - Skin of colour: no; yes - Affected area (select all that apply): skin; hair; nail; mucosa - Morphology: macule/patch; papule/plaque; vesicle/bulla; nodule; other Collect 9 observations of achievement - At least 1 of each affected area - At least 1 of each morphology - At least 3 different assessors

    Suggested observations: 9

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatric

    Skin of colour

    1. no
    2. yes

    Affected area

    1. skin
    2. hair
    3. nail
    4. mucosa

    Morphology

    1. macule/patch
    2. papule/plaque
    3. vesicle/bulla
    4. nodule
    5. other

    Medical Expert

    • ME 2.2 Perform a physical examination relevant to the presentation
    • ME 2.2 Use special examination techniques, as relevant
    • ME 2.2 Describe the morphology of the lesion(s), using appropriate terminology
    • ME 2.2 Classify the lesion(s) based on morphology
    • ME 2.2 Develop a differential diagnosis
    • ME 2.2 Propose a most likely diagnosis for common disorders

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-2

    Performing punch and shave biopsies

    Key features and assessment plan

    - This EPA includes obtaining and documenting informed consent, selecting the appropriate biopsy technique, selecting and preparing the biopsy site, and performing the procedure, specimen handling (i.e. correct container and fixative, requisitions) and wound closure and dressing, as applicable.

    Direct observation by supervisor or Core or TTP resident Use Form 1. Form collects information on: - Biopsy: punch; shave; other Collect 6 observations of achievement - At least 3 shave biopsies - At least 3 punch biopsies - At least 2 different assessors - At least 1 dermatologist assessor

    Suggested observations: 6

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Biopsy

    1. punch
    2. shave
    3. other

    Medical Expert

    • ME 3.2 Obtain and document informed consent, explaining the risks and rationale for the biopsy
    • ME 3.1 Select the appropriate biopsy site, technique, and sample medium
    • ME 3.4 Demonstrate clean technique, establish and respect the sterile field, and maintain universal precautions
    • ME 3.4 Perform the procedure in a skilful and safe manner
    • ME 3.4 Complete the pathology requisition accurately and completely
    • ME 3.4 Establish and implement a plan for post-procedure care

    Communicator

    • COM 3.1 Communicate effectively with the patient during the procedure

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-3

    Recognizing the acuity of a patient’s illness, initiating stabilization and management, and consulting as ne…

    Key features and assessment plan

    - This EPA focuses on recognizing that a patient is or is likely to become critically ill, and responding appropriately. - This includes prioritizing actions, implementing the primary priorities of resuscitation (airway, breathing, and circulation), and providing targeted treatment. - An important aspect of this EPA is the timely and appropriate recognition of the need for assistance and/or definitive management. - The observation of this EPA must include pediatric and adult patients.

    Direct observation or case review by supervisor or Core or TTP resident Use Form 1. Form collects information on: - Demographic: adult; pediatric - Settings: emergency department; inpatient; outpatient Collect 2 observations of achievement - At least 1 adult patient - At least 1 pediatric patient - At least 1 in acute setting (emergency department or inpatient)

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatric

    Settings

    1. emergency department
    2. inpatient
    3. outpatient

    Medical Expert

    • ME 2.1 Determine the acuity of the situation and the priorities for patient care
    • ME 2.2 Provide assessment and initial stabilization of ABCs
    • ME 2.2 Perform a history and physical examination relevant to the patient presentation, in a time-effective manner
    • ME 2.2 Select and/or interpret investigations
    • ME 2.4 Develop and implement a plan for initial management
    • ME 4.1 Determine the appropriate disposition and/or setting for ongoing care

    Collaborator

    • COL 1.3 Work effectively with other members of the health care team

    Professional

    • P 1.1 Work within personal limits, asking for assistance as needed

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-4

    Assessing and providing initial management for patients with acute presentations of common illnesses

    Key features and assessment plan

    - This EPA includes performing a history and physical examination for a patient with a new presentation or an exacerbation of a pre-existing illness. - It also includes developing a differential diagnosis and initial management plan and presenting the case to a supervisor. - This includes both adult and pediatric patients, and a broad range of medical and surgical conditions. - This EPA does not include assessing and managing patients who are critically ill or have complex multisystem problems.

    Direct observation or case review by supervisor or Core or TTP resident Use Form 1. Form collects information on: - Observation: direct; case review - Demographic: adult; pediatric - Type of condition: allergic/immunologic; cardiac; endocrine; GI; hematologic; neurologic; renal; respiratory; other Collect 6 observations of achievement - At least 2 pediatric patients - At least 1 direct observation of an adult patient - At least 1 direct observation of a pediatric patient - At least 3 different types of conditions - At least 3 observations by staff - At least 3 different assessors

    Suggested observations: 6

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Observation

    1. direct
    2. case review

    Demographic

    1. adult
    2. pediatric

    Type of condition

    1. allergic/immunologic
    2. cardiac
    3. endocrine
    4. GI
    5. hematologic
    6. neurologic
    7. renal
    8. respiratory
    9. other

    Medical Expert

    • ME 2.2 Gather a relevant clinical history
    • ME 2.2 Perform a physical examination relevant to the presentation
    • ME 2.2 Select and/or interpret investigations
    • ME 2.2 Develop a differential diagnosis
    • ME 2.4 Develop a management plan
    • ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor

    Communicator

    • COM 2.1 Use patient-centred interviewing skills, and inclusive and person-first language
    • COM 2.3 Seek and synthesize relevant information from other sources (e.g. family, medical record)

    Collaborator

    • COL 1.2 Work effectively as a member of the clinical team

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-5

    Assessing and managing patients with common chronic conditions

    Key features and assessment plan

    - This EPA focuses on clinical assessment and development of a basic management plan that may include implementing screening, surveillance, or monitoring strategies, assessing medication adherence and effects, recognizing the need for change of therapy, and determining the need for follow-up. - This includes adult and pediatric patients in any care setting.

    Direct observation or case review by supervisor or Core or TTP resident Use Form 1. Form collects information on: - Observation: direct; case review - Demographic: adult; pediatric - Type of condition: allergic/immunologic; cardiac; endocrine; GI; hematologic; neurologic; renal; respiratory; other Collect 6 observations of achievement - At least 2 pediatric patients - At least 1 direct observation of an adult patient - At least 1 direct observation of a pediatric patient - At least 3 different types of conditions - At least 3 observations by staff - At least 3 different assessors

    Suggested observations: 6

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Observation

    1. direct
    2. case review

    Demographic

    1. adult
    2. pediatric

    Type of condition

    1. allergic/immunologic
    2. cardiac
    3. endocrine
    4. GI
    5. hematologic
    6. neurologic
    7. renal
    8. respiratory
    9. other

    Medical Expert

    • ME 2.2 Gather a relevant clinical history
    • ME 2.2 Perform a physical examination relevant to the presentation
    • ME 2.2 Select and/or interpret investigations
    • ME 2.2 Assess the patient for response to therapy, complications, and/or status of their chronic condition
    • ME 2.4 Develop a management plan

    Collaborator

    • COL 1.3 Integrate the patient’s and/or family’s perspective into the care plan

    Health Advocate

    • HA 1.2 Work with the patient and/or family to increase their understanding of their illness and health care needs

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-6

    Assessing patients with a rheumatologic disease

    Key features and assessment plan

    - This EPA focuses on the aspects of rheumatologic diseases most relevant to dermatology practice. - This includes gathering a history and performing a relevant physical examination with a focus on recognizing cutaneous manifestations and assessing joint activity, reviewing and interpreting results of investigations and summarizing the findings for oral presentation to a supervisor. - This EPA includes a review of systems as it relates to rheumatologic diseases, enquiring for extra-articular manifestations. - It may also include participating in the development of a management plan.

    Direct observation or case review with verification of pertinent findings by dermatologist, rheumatologist, or Core or TTP rheumatology resident Use Form 1. Form collects information on: - MSK exam observed: no; yes - Case mix: inflammatory arthritis; non-inflammatory arthritis; connective tissue disease; vasculitis; other Collect at least 4 observations of achievement - At least 1 observation of an MSK exam by a rheumatologist - At least 1 patient with inflammatory arthritis observed by a rheumatologist - At least 1 patient with non-inflammatory arthritis observed by a rheumatologist - At least 1 patient with connective tissue disease - At least 1 patient with vasculitis - At least 2 different assessors - No more than 1 observation by a subspecialty resident

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    MSK exam observed

    1. no
    2. yes

    Case mix

    1. inflammatory arthritis
    2. non-inflammatory arthritis
    3. connective tissue disease
    4. vasculitis
    5. other

    Medical Expert

    • ME 2.2 Gather a relevant clinical history
    • ME 2.2 Elicit pertinent information from a review of systems
    • ME 2.2 Perform an MSK physical examination using appropriate technique for joint examinations
    • ME 2.2 Perform a physical examination for relevant extra-articular manifestations of rheumatologic disease
    • ME 2.2 Perform the physical examination in a manner that minimizes discomfort or distress
    • ME 2.2 Select and/or interpret investigations
    • ME 2.2 Develop a differential diagnosis
    • ME 2.4 Develop a management plan
    • ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor

    Communicator

    • COM 2.1 Use patient-centred interviewing skills, and inclusive and person-first language

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-7

    Assessing patients with an infectious disease

    Key features and assessment plan

    - This EPA focuses on the aspects of infectious diseases most relevant to Dermatology practice. - This includes gathering a history and performing a relevant physical examination with a focus on recognizing cutaneous manifestations, reviewing results of investigations, and summarizing the findings for oral presentation to a supervisor. - It also includes participating in the development of a management plan. - This includes patients presenting with cutaneous manifestation of viral, bacterial, mycobacterial, fungal and deep fungal infections, and infestations.

    Direct observation or case review by infectious disease specialist or Core or TTP subspecialty resident Use Form 1. Form collects information on: - Setting: clinic; ward; ICU - Skin findings: no; yes Collect 4 observations of achievement - At least 1 in inpatient setting (ward or ICU) - At least 2 different assessors - No more than 2 observations by Core or TTP resident

    Suggested observations: 4

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Setting

    1. clinic
    2. ward
    3. ICU

    Skin findings

    1. no
    2. yes

    Medical Expert

    • ME 2.2 Gather a relevant clinical history
    • ME 2.2 Perform a physical examination relevant to the presentation
    • ME 2.2 Select and/or interpret investigations
    • ME 2.2 Develop a differential diagnosis
    • ME 2.4 Develop a management plan
    • ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor

    Communicator

    • COM 2.3 Seek and synthesize relevant information from other sources (e.g. family, medical record)

    Professional

    • P 1.1 Maintain universal precautions

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-8

    Documenting clinical encounters

    Key features and assessment plan

    - This EPA focuses on the application of written communication skills in a variety of formats: consultation letters, progress notes, handover notes and discharge summaries. - This includes a synthesis of the pertinent clinical findings, investigations and management plan, and documenting the findings in an organized and well summarized manner. - The documents submitted for review must be the sole work of the resident. - This EPA may be observed in any care setting and with any patient presentation.

    Document review by supervisor or Core, TTP or subspecialty resident Use Form 1. Form collects information on: - Demographic: adult; pediatric - Experience: dermatology; emergency medicine; infectious disease; internal medicine; pediatrics; rheumatology; other - Type of documentation: consult report; progress note; clinic note; discharge letter; admission note; other (write in) Collect 5 observations of achievement - At least 2 pediatric - At least 1 rheumatology encounter - A variety of types of documentation

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatric

    Experience

    1. dermatology
    2. emergency medicine
    3. infectious disease
    4. internal medicine
    5. pediatrics
    6. rheumatology
    7. other

    Type of documentation

    1. consult report
    2. progress note
    3. clinic note
    4. discharge letter
    5. admission note
    6. other (write in)

    Medical Expert

    • ME 2.2 Synthesize and interpret information from the clinical assessment

    Communicator

    • COM 5.1 Organize information in appropriate sections
    • COM 5.1 Document all relevant findings and investigations
    • COM 5.1 Convey clinical reasoning and the rationale for decisions
    • COM 5.1 Provide a clear plan for ongoing management
    • COM 5.1 Complete clinical documentation in a timely manner

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-9

    Communicating with patients and/or families about clinical findings and management plans

    Key features and assessment plan

    - This EPA focuses on the application of communication skills and medical expertise to convey medical assessments, diagnoses, and treatment plans. - It does not include managing challenging conversations, such as end-of-life discussions or disclosure of adverse events.

    Direct observation by supervisor, Core, TTP or subspecialty resident, or other health professional Use Form 1. Form collects information on: - Patient demographic: pediatric; adult - Setting: inpatient; outpatient - Topic discussed (write in): Collect 5 observations achievement - At least 1 adult patient - At least 1 pediatric patient - A variety of settings - A variety of topics - A variety of observers

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Patient demographic

    1. pediatric
    2. adult

    Setting

    1. inpatient
    2. outpatient

    Communicator

    • COM 1.1 Establish rapport with the patient and/or family
    • COM 1.6 Tailor the approach to communication to the needs of the patient and/or family
    • COM 1.1 Engage the patient in the discussion as appropriate for their developmental stage
    • COM 3.1 Provide accurate information about medical condition and management plan
    • COM 3.1 Use plain language and avoid medical jargon
    • COM 4.3 Solicit and answer questions from the patient and/or family
    • COM 3.1 Verify and validate the patient and/or family’s understanding
    • COM 4.2 Use communication skills and strategies that help the patient and/or family make informed decisions
    • COM 4.1 Communicate in a manner that is respectful, non-judgmental and culturally aware

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • F-10

    Working effectively as a member of the interprofessional team

    Key features and assessment plan

    - This EPA focuses on the role of the physician as a member of the interprofessional clinical team. - This includes contributing to the work of the team, understanding and respecting the roles of other team members, and demonstrating appropriate professional behaviours. - The observation of this EPA is based on a period of time of at least one week.

    Direct and indirect observation by supervisor, with input from other members of the interprofessional team Use Form 1. Form collects information on: - Experience: dermatology; emergency medicine; infectious disease; internal medicine; pediatrics; rheumatology; other - Includes input from (select all that apply): other supervisor(s); nurse(s); other physician(s); other health care professional(s); resident(s) or student(s); other Collect feedback during at least 2 rotations - At least 2 different clinical experiences - At least 2 observations that include input from nurses and/or other health professionals

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Experience

    1. dermatology
    2. emergency medicine
    3. infectious disease
    4. internal medicine
    5. pediatrics
    6. rheumatology
    7. other

    Includes input from

    1. other supervisor(s)
    2. nurse(s)
    3. other physician(s)
    4. other health care professional(s)
    5. resident(s) or student(s)
    6. other

    Collaborator

    • COL 1.2 Demonstrate an understanding of the scope and expertise of other health care professionals
    • COL 1.3 Communicate effectively with physicians and other health care professionals
    • COL 1.1 Respond appropriately to input from other health care professionals
    • COL 1.1 Accept feedback in the spirit of cooperation and learning

    Professional

    • P 1.1 Demonstrate punctuality
    • P 1.1 Complete assigned responsibilities
    • P 1.1 Behave in a professional manner
    • P 1.1 Respond punctually to requests from patients or other health care professionals

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

Core

  • C-1

    Recognizing and managing dermatologic emergencies in children and adults

    Key features and assessment plan

    - This EPA focuses on the recognition, timely assessment, and management of a variety of dermatologic emergencies with secondary systemic sequelae. - It includes assessing the patient, selecting, ordering and interpreting investigations, and providing or arranging for appropriate management. - An important aspect of this EPA is the timely and appropriate recognition of the need for assistance or consultation with other physicians, and provision of advice regarding the acuity, risk of clinical deterioration and appropriate setting of care (i.e. ICU, monitored bed, warmed room etc).

    Direct observation, or case review with verification of pertinent findings by supervisor, TTP resident or fellow Use Form 1. Form collects information on: - Demographic: adult; pediatrics - Setting: clinic; emergency department; ward; ICU - Diagnosis (write in): Collect 5 observations of achievement - At least 1 pediatric case - At least 2 different assessors

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatrics

    Setting

    1. clinic
    2. emergency department
    3. ward
    4. ICU

    Medical Expert

    • ME 2.1 Determine the acuity of the situation and the priorities for patient care
    • ME 1.5 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Select and/or interpret investigations
    • ME 2.2 Integrate the clinical data to establish the diagnosis and severity of the condition
    • ME 2.4 Determine the appropriate setting for ongoing care
    • ME 2.4 Develop a management plan
    • ME 4.1 Determine if there is a need for consultation with another specialist or service

    Collaborator

    • COL 1.2 Work effectively with members of the interprofessional team to implement a management plan

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-2

    Providing consultation for hospitalized patients with a dermatologic condition

    Key features and assessment plan

    - This EPA focuses on patients with a new presentation of a dermatologic condition. - This includes clinical assessment, selection and/or interpretation of investigations (including interpreting pathology results), and development and implementation of a management plan. - This EPA also includes working effectively with the referring service.

    Direct observation or case review with verification of pertinent findings by supervisor, TTP resident or fellow Use Form 1. Form collects information on: - Type of observation: direct; case review - Demographic: adult; pediatric - Skin of colour: no; yes - Complex case: no; yes - Category: infection/infestation; inflammatory/immunologic; neoplasm, proliferation or cyst; genetic/developmental; iatrogenic, including adverse drug reaction; occupational/provoked by external factors; metabolic/nutritional; sensory/psychological; hair, nail, mucous membrane and/or appendage; disorder in pregnancy/neonatal period Collect 10 observations of achievement - At least 2 direct observations - At least 2 pediatric patients - At least 1 patient with skin of colour - At least 6 complex cases (adult or pediatric) - At least 1 complex pediatric cases - A variety of categories of condition - At least 4 different assessors

    Suggested observations: 10

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Type of observation

    1. direct
    2. case review

    Demographic

    1. adult
    2. pediatric

    Skin of colour

    1. no
    2. yes

    Complex case

    1. no
    2. yes

    Category

    1. infection/infestation
    2. inflammatory/immunologic
    3. neoplasm, proliferation or cyst
    4. genetic/developmental
    5. iatrogenic, including adverse drug reaction
    6. occupational/provoked by external factors
    7. metabolic/nutritional
    8. sensory/psychological
    9. hair, nail, mucous membrane and/or appendage
    10. disorder in pregnancy/neonatal period

    Medical Expert

    • ME 2.1 Determine the acuity of the situation and the priorities for patient care
    • ME 1.5 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Formulate a differential and most likely diagnosis
    • ME 2.2 Select, prioritize and/or interpret investigations
    • ME 2.4 Develop a management plan
    • ME 4.1 Develop a plan for follow-up on investigations and monitor response to treatment

    Communicator

    • COM 3.1 Provide information to the patient about the diagnosis and management plan

    Collaborator

    • COL 1.3 Communicate effectively with the consulting service

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-3

    Providing consultation for patients in the outpatient setting

    Key features and assessment plan

    - This EPA focuses on patients with a new presentation of a dermatologic condition. - This includes clinical assessment, selection and/or interpretation of investigations (including interpreting pathology results), and development and implementation of a management plan. - This EPA may be observed in any dermatology clinic, including general, specialty and outreach clinics.

    Direct observation or case review with verification of pertinent findings by supervisor, TTP resident or fellow Use Form 1. Form collects information on: - Demographic: adult; pediatric - Skin of colour: no; yes - Complex case: no; yes - Category: infection/infestation; inflammatory/immunologic; neoplasm, proliferation or cyst; genetic/developmental; iatrogenic, including adverse drug reaction; occupational/provoked by external factors; metabolic/nutritional; sensory/psychological; hair, nail, mucous membrane and/or appendage; disorder in pregnancy/neonatal period - Diagnosis (write in): Collect 35 observations of achievement - At least 10 pediatric patients - At least 2 patients with skin of colour - At least 10 complex cases (adult or pediatric) - At least 1 case in each of the categories of condition

    Suggested observations: 35

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatric

    Skin of colour

    1. no
    2. yes

    Complex case

    1. no
    2. yes

    Category

    1. infection/infestation
    2. inflammatory/immunologic
    3. neoplasm, proliferation or cyst
    4. genetic/developmental
    5. iatrogenic, including adverse drug reaction
    6. occupational/provoked by external factors
    7. metabolic/nutritional
    8. sensory/psychological
    9. hair, nail, mucous membrane and/or appendage
    10. disorder in pregnancy/neonatal period

    Medical Expert

    • ME 2.2 Gather a history and perform a physical examination relevant to the presentation
    • ME 2.2 Formulate a differential and most likely diagnosis
    • ME 2.2 Select, prioritize and/or interpret investigations
    • ME 2.4 Develop a management plan

    Communicator

    • COM 3.1 Provide information to the patient about the diagnosis and management plan
    • COM 5.1 Write prescriptions clearly, with attention to atypical dosing and frequency

    Health Advocate

    • HA 1.2 Provide education resources and facilitate services for the patient and/or family

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-4

    Providing ongoing management for patients with a chronic dermatologic condition

    Key features and assessment plan

    - This EPA focuses on providing ongoing comprehensive management that includes assessing clinical status and response to treatment, assessing medication adherence and effects, implementing monitoring strategies, managing disease-related symptoms, as well as addressing patient concerns and providing patient education. - This includes identifying patients with a fluctuating clinical course, recognizing the need for change or escalation of therapy, and implementing a therapeutic plan. - It also includes arranging follow-up or discharging the patient back to the care of the referring physician, when appropriate. - This EPA must be observed across a range of conditions.

    Direct observation or case review with verification of pertinent findings by supervisor, TTP resident or fellow Use Form 1. Form collects information on: - Demographic: adult; pediatric - Skin of colour: no; yes - Complex case: no; yes - Category: infection/infestation; inflammatory/immunologic; neoplasm, proliferation or cyst; genetic/developmental; iatrogenic, including adverse drug reaction; occupational/provoked by external factors; metabolic/nutritional; sensory/psychological; hair, nail, mucous membrane and/or appendage; disorder in pregnancy/neonatal period Collect 35 observations of achievement - At least 6 pediatric patients - At least 2 patients with skin of colour - At least 10 complex cases - At least 5 inflammatory/immunologic conditions - At least 3 of each of the other categories of condition - At least 5 different assessors

    Suggested observations: 35

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatric

    Skin of colour

    1. no
    2. yes

    Complex case

    1. no
    2. yes

    Category

    1. infection/infestation
    2. inflammatory/immunologic
    3. neoplasm, proliferation or cyst
    4. genetic/developmental
    5. iatrogenic, including adverse drug reaction
    6. occupational/provoked by external factors
    7. metabolic/nutritional
    8. sensory/psychological
    9. hair, nail, mucous membrane and/or appendage
    10. disorder in pregnancy/neonatal period

    Medical Expert

    • ME 2.2 Synthesize patient information to determine clinical status, response to treatment and/or toxicity
    • ME 2.2 Interpret the results of investigations performed to monitor the condition and/or treatment
    • ME 2.2 Assess adherence to treatment
    • ME 2.4 Develop a plan for management, which may include modification of current therapy
    • ME 4.1 Determine the frequency and timing of future investigations and visits

    Communicator

    • COM 4.2 Facilitate self care and chronic disease management

    Collaborator

    • COL 1.3 Integrate the patient’s and family’s perspective and context into the care plan
    • COL 3.1 Determine when care should be transferred back to a primary care provider

    Leader

    • L 2.1 Consider costs and resource availability when selecting diagnostic or treatment options

    Health Advocate

    • HA 1.3 Incorporate prevention, health promotion and health surveillance into the patient interaction

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-5

    Initiating and monitoring systemic therapy

    Key features and assessment plan

    - This EPA focuses on selecting patients that may benefit from systemic therapy, and assessing the risk of therapy both at initiation and as part of ongoing treatment. - This includes evaluation for relevant co-morbidities and toxicities, and the appropriate choice and prescription of treatment and associated supportive medications for patients with a range of conditions. - It also includes discussing the treatment with the patient to obtain informed consent. - This EPA includes all forms of systemic therapy, including but not limited to systemic corticosteroids, conventional immunomodulatory agents (e.g. methotrexate, hydroxychloroquine, mycophenolate, cyclosporin, sulfasalazine, dapsone), targeted therapies (e.g. biologics), retinoids, antibacterial/antifungals and antivirals, and other medications, as well as phototherapy.

    Direct observation and/or case review by supervisor or TTP resident Use Form 1. Form collects information on: - Treatment (select all that apply): systemic corticosteroid; conventional immunomodulatory agent; targeted therapy; retinoid; antibacterial; antiviral; antifungal; phototherapy; other - Specific medication (write in): Collect 15 observations of achievement - At least 1 systemic corticosteroid - At least 4 different conventional immunomodulatory agents - At least 3 different targeted therapies - At least 2 retinoids (1 must be isotretinoin) - At least 1 antibacterial - At least 1 antiviral - At least 1 antifungal - At least 2 phototherapy

    Suggested observations: 15

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Treatment

    1. systemic corticosteroid
    2. conventional immunomodulatory agent
    3. targeted therapy
    4. retinoid
    5. antibacterial
    6. antiviral
    7. antifungal
    8. phototherapy
    9. other

    Medical Expert

    • ME 2.2 Assess the patient’s health status, including the status of their dermatologic condition and any concurrent illnesses
    • ME 1.3 Apply knowledge of systemic therapy, including pharmacology, potential adverse events and their prevention/management
    • ME 2.4 Select an appropriate treatment and regimen
    • ME 3.2 Provide information to the patient about the indications, contraindications, risks, and alternatives for a given treatment plan
    • ME 3.2 Use shared decision-making in the consent process
    • ME 2.4 Implement any required adjustments in dosing or regimen based on the patient's health status or concurrent illnesses
    • ME 2.4 Select and prescribe supportive care to mitigate adverse effects
    • ME 2.4 Implement monitoring strategies

    Health Advocate

    • HA 1.1 Facilitate patient’s access to needed medications

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-6

    Assessing and providing management for patients with chronic wounds

    Key features and assessment plan

    - This EPA focuses on assessment and determination of the nature of the wound, including relevant investigations such as medical imaging, wound biopsy and culture as relevant, as well as selection/application of appropriate dressings, compression and other aspects of wound care, and determination as to whether surgical intervention is needed. - This includes: history and physical examination, identification of risk factors/risk stratification (i.e. nutrition, smoking, diabetes, ambulatory status, moisture, pressure relief), and discussion of management options and potential risks/complications. - This EPA may be observed in the clinic or on the inpatient service.

    Direct observation or case review by supervisor or TTP resident Use Form 1. Form collects information on: - Type of wound: traumatic; inflammatory; neuropathic; decubitus; venous; arterial; mixed; other - Management (select all that apply): dressing; compression; surgical Collect 3 observations of achievement - A variety of types of wounds - At least 1 venous

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Type of wound

    1. traumatic
    2. inflammatory
    3. neuropathic
    4. decubitus
    5. venous
    6. arterial
    7. mixed
    8. other

    Management

    1. dressing
    2. compression
    3. surgical

    Medical Expert

    • ME 2.2 Gather a history and perform a physical examination relevant to the presentation
    • ME 2.2 Identify patient factors that predispose to poor wound healing
    • ME 2.2 Select and/or interpret investigations
    • ME 2.4 Develop a management plan
    • ME 2.4 Provide wound care, including appropriate dressings, antimicrobials and/or wound care systems as needed
    • ME 4.1 Determine whether there is a need to refer for surgical intervention
    • ME 4.1 Establish a plan for ongoing care and/or follow-up of results of investigations

    Health Advocate

    • HA 1.1 Work with the patient to address lifestyle factors that impact their health

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-7

    Managing the care of patients with skin cancer

    Key features and assessment plan

    - This EPA focuses on interpreting a pathology report, including assessing the surgical margins, considering options for treatment, and establishing a management plan with the patient. - An important part of this EPA is effective communication with the patient and family. - This EPA includes all skin malignancies, primary and metastatic.

    Direct observation and/or case review by supervisor or TTP resident Use Form 1. Form collects information on: - Presentation: basal cell carcinoma; invasive melanoma; non-invasive melanoma; squamous cell carcinoma; other skin cancer - Management (select all that apply): active non-intervention; topical; electrodesiccation and curettage; wide local excision; Mohs; sentinel lymph node biopsy; radiation; other Collect 7 observations of achievement - At least 2 basal cell carcinoma - At least 2 melanoma - At least 1 invasive melanoma - At least 2 squamous cell carcinoma - At least 1 other skin cancer - At least 5 different management options - At least 2 different assessors

    Suggested observations: 7

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Presentation

    1. basal cell carcinoma
    2. invasive melanoma
    3. non-invasive melanoma
    4. squamous cell carcinoma
    5. other skin cancer

    Management

    1. active non-intervention
    2. topical
    3. electrodesiccation and curettage
    4. wide local excision
    5. Mohs
    6. sentinel lymph node biopsy
    7. radiation
    8. other

    Medical Expert

    • ME 2.2 Interpret the results of investigations done for diagnosis and/or staging (pathology, imaging, tumour markers)
    • ME 2.2 Identify features of the patient’s condition or co-morbidities which modify the risk of disease progression and/or treatment
    • ME 4.1 Determine the need and timing of referral to another physician or surgeon
    • ME 2.4 Develop and implement a plan, which may include further investigation, surveillance, medical treatment and/or surgical intervention
    • ME 3.1 Provide information about the proposed management plan, including the risks, benefits and potential alternative treatments

    Communicator

    • COM 3.1 Provide information on diagnosis and prognosis clearly and compassionately
    • COM 4.2 Use communication skills and strategies that help the patient and/or family make informed decisions

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-8

    Performing and interpreting dermoscopy

    Key features and assessment plan

    - This EPA focuses on the technical skills of performing dermoscopy as well as interpreting the examination. - This includes a systematic approach to identifying and describing findings and making a diagnosis.

    Direct observation or case review with dermatologist or TTP resident Use Form 1. Form collects information on: - Patient demographic: pediatric; adult - Skin of colour: no; yes - Assessment of: pigmented lesion; keratinocyte carcinoma; nail; hair; other Collect 15 observations of achievement - At least 1 pediatric patient - At least 1 patient with skin of colour - At least 5 pigmented lesions - At least 5 keratinocyte carcinomas - At least 2 assessments of nail - At least 2 assessments of hair - At least 2 different assessors

    Suggested observations: 15

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Patient demographic

    1. pediatric
    2. adult

    Skin of colour

    1. no
    2. yes

    Assessment of

    1. pigmented lesion
    2. keratinocyte carcinoma
    3. nail
    4. hair
    5. other

    Medical Expert

    • ME 2.2 Utilize non-contact, contact, polarized, or non-polarized technique as appropriate
    • ME 2.2 Perform a dermoscopic assessment and identify key features of the lesion
    • ME 1.3 Apply knowledge of the dermoscopic features of skin disorders to classify the lesion
    • ME 2.2 Determine the diagnosis
    • ME 2.2 Ensure instrument is cleaned between patients

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-9

    Performing and interpreting patch testing

    Key features and assessment plan

    - This EPA focuses on all aspects of preparing for and interpreting patch testing, as well as providing counselling regarding the findings. - This includes applying an understanding of the factors that can influence the accuracy, reliability, or safety of procedures in patch testing (e.g., dermatographism, causes of false positive and false negative test results). - The application and removal of a patch test must be observed at least once.

    Direct observation by dermatologist, allergist/immunologist, or patch testing nurse Use Form 1. Form collects information on: - Skin of colour: no; yes - Patch test application/removal: no; yes - Occupational counselling: no; yes Collect 3 observations of achievement - 1 patch test application and removal - At least 1 with occupational counselling

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Skin of colour

    1. no
    2. yes

    Patch test application/removal

    1. no
    2. yes

    Occupational counselling

    1. no
    2. yes

    Medical Expert

    • ME 2.2 Gather a history and perform a physical examination relevant to the presentation
    • ME 2.2 Identify potential exposures
    • ME 3.2 Describe the patch test procedure and explain the risks and benefits of, and the rationale for the procedure
    • ME 3.4 Select the appropriate series for patch testing based on potential exposures
    • ME 3.4 Assess the quality of the test and any impact on diagnostic interpretation
    • ME 2.2 Identify findings of clinical significance

    Communicator

    • COM 3.1 Provide information to the patient regarding the implications of the findings

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-10

    Performing the procedures of Dermatology

    Key features and assessment plan

    - This EPA includes demonstrating knowledge of the procedure, specific indications and contraindications, risks and benefits, and common complications, and obtaining informed consent, as well as performing the procedure and completing post- procedure documentation. - This includes the following procedures: shave biopsy, scissor biopsy, incisional biopsy, elliptical excision, wide local excision, undermining, electrodesiccation and curettage, electrocautery, cryotherapy, and intralesional injection. - This EPA includes procedures done in sites with specific anatomic concerns, such as anatomic lines (e.g. face) and areas with high vasculature/nervous supply (e.g. hands, feet).

    Direct observation by supervisor, TTP resident or fellow Use Form 1. Form collects information on: - Demographic: age <10; age 10–18; adult - Skin of colour: no; yes - Procedure (select all that apply): shave biopsy; punch biopsy; elliptical biopsy; wide local excision; intralesional injection: electrodesiccation and curettage; cryotherapy; other - Special site: no; yes Collect at least 20 observations of achievement - At least 3 procedures in children <10 - At least 2 procedures in patients with skin of colour - At least 3 shave biopsies in special sites - At least 3 punch biopsies in special sites - At least 3 elliptical biopsies or wide local excisions, including special sites - At least 3 intralesional injections - At least 3 electrodesiccation and curettage, which may include special sites - At least 3 patients receiving cryotherapy, including special sites - At least 3 different supervisors

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. age <10
    2. age 10–18
    3. adult

    Skin of colour

    1. no
    2. yes

    Procedure

    1. shave biopsy
    2. punch biopsy
    3. elliptical biopsy
    4. wide local excision
    5. intralesional injection: electrodesiccation and curettage
    6. cryotherapy
    7. other

    Special site

    1. no
    2. yes

    Medical Expert

    • ME 3.2 Obtain informed consent, explaining the risks, rationale, and alternatives to the proposed procedure
    • ME 3.4 Assemble/gather the appropriate equipment and materials
    • ME 3.4 Demonstrate clean technique, establish and respect the sterile field, and maintain universal precautions
    • ME 3.4 Select and provide local and/or regional anaesthesia, as relevant
    • ME 3.4 Perform the procedure in a skilful and safe manner
    • ME 3.4 Monitor patient comfort and safety, and adjust the procedure as needed
    • ME 3.4 Establish and implement a plan for post-procedure care

    Communicator

    • COM 3.1 Communicate effectively with patient and/or assistant(s) during the procedure
    • COM 5.1 Document the procedure and outcome

    Professional

    • P 1.1 Work within personal limits, asking for assistance as needed

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-11

    Assessing patients for an aesthetic procedure

    Key features and assessment plan

    - This EPA includes clinical assessment, selection of appropriate procedural options, and a review of risks and complications in a discussion of informed consent. - The procedures to be considered include: neurotoxin injection, soft tissue filler, chemical peel, and laser and energy-based device procedures. - The observation of this EPA is divided into two parts: patient assessment; and, performing a procedure.

    Part A: Patient assessment Direct observation and/or case review by dermatologist Use Form 1. Form collects information on: - Procedure discussed: neurotoxin; soft tissue filler; chemical peel; laser and energy- based device - Skin of colour: no; yes - Setting: clinical; simulation Collect 2 observations of achievement - 2 different procedures Part B: Procedure Direct observation by dermatologist or plastic surgeon Use Form 1. Form collects information on: - Procedure: neurotoxin; soft tissue filler; chemical peel; laser and energy-based device - Skin of colour: no; yes - Setting: clinical; simulation Collect 2 observations of achievement - 2 different procedures

    Suggested observations: 2

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Procedure discussed

    1. neurotoxin
    2. soft tissue filler
    3. chemical peel
    4. laser and energy- based device

    Skin of colour

    1. no
    2. yes

    Setting

    1. clinical
    2. simulation

    Medical Expert

    • Part A: ME 2.2 Gather a history and perform a physical examination relevant to the presentation
    • Part A: ME 2.2 Assess the psychological and social factors contributing to a request for an aesthetic/cosmetic procedure
    • Part A: ME 2.3 Ascertain and manage patient expectations
    • Part A: ME 3.1 Determine the appropriate procedure
    • Part A: ME 3.2 Obtain informed consent, explaining the risks, rationale, and alternatives to the proposed procedure
    • Part B: ME 3.4 Assemble/gather the appropriate equipment and materials
    • Part B: ME 3.1 Select the appropriate dosing, volumes, or settings for the procedure and the patient
    • Part B: ME 3.4 Demonstrate clean technique, establish and respect the sterile field, and maintain universal precautions
    • Part B: ME 3.4 Perform the procedure in a skilful and safe manner
    • Part B: ME 3.4 Monitor patient comfort and safety, and adjust the procedure as needed
    • Part B: ME 3.4 Establish and implement a plan for post-procedure care

    Communicator

    • Part A: COM 1.1 Recognize and respect the patient’s psychological and emotional needs
    • Part A: COM 3.1 Use plain language and avoid medical jargon
    • Part A: COM 5.1 Document the discussion regarding informed consent in an accurate and complete manner
    • Part B: COM 3.1 Communicate effectively with patient and/or assistant(s) during the procedure
    • Part B: COM 5.1 Document the procedure and outcome

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-12

    Providing care for patients who have had a complication of a treatment or procedure

    Key features and assessment plan

    - This EPA includes recognizing, investigating, and managing complications resulting from diagnostic or therapeutic procedures or interventions.

    Direct observation and/or case review by supervisor or TTP resident Use Form 1. Form collects information on: - Complication: medical; surgical - Demographic: adult; pediatric Collect 5 observations of achievement - At least 2 surgical complications - At least 2 medical complications - At least 2 different assessors

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Complication

    1. medical
    2. surgical

    Demographic

    1. adult
    2. pediatric

    Medical Expert

    • ME 1.5 Perform a clinical assessment that addresses all relevant issues
    • ME 2.2 Identify factors contributing to a complication of a dermatologic procedure and/or intervention
    • ME 2.2 Select and/or interpret investigations
    • ME 2.4 Develop a management plan
    • ME 4.1 Develop a plan to follow up on investigations and monitor response to treatment

    Communicator

    • COM 3.2 Disclose an adverse event and/or outcome to the patient and/or family

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-13

    Counselling patients and families for the purposes of disease management, prevention and health promotion

    Key features and assessment plan

    - This EPA focuses on clearly conveying information, promoting healthy behaviours and engaging the patient and/or family in their care. - This may include teaching the patient and/or family about their condition, its management, and/or preventive measures. - This EPA may be observed in a simulation setting.

    Direct observation by supervisor, which may include input from other health care professionals or patient/family Use Form 1. Form collects information on: - Demographic: adult; pediatric - Theme: disease/treatment education; disease prevention; health promotion - Topic (write in): Collect 3 observations of achievement - At least 1 pediatric

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Demographic

    1. adult
    2. pediatric

    Theme

    1. disease/treatment education
    2. disease prevention
    3. health promotion

    Medical Expert

    • ME 2.3 Address with the patient and/or family their ideas about the nature and cause of the condition, fears and concerns, and/or expectations of health care professionals

    Communicator

    • COM 3.1 Provide information and explanations that are clear and accurate
    • COM 3.1 Use plain language and avoid medical jargon
    • COM 4.3 Solicit and answer questions from the patient and/or family

    Health Advocate

    • HA 1.2 Work with the patient and/or family to increase their understanding of their illness and health care needs
    • HA 1.2 Provide education resources and facilitate services for the patient and/or family
    • HA 1.3 Implement strategies for disease prevention, health promotion and health surveillance
    • HA 1.1 Facilitate timely patient access to services and resources

    Professional

    • P 1.1 Demonstrate respect for patient autonomy

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-14

    Leading discussions with patients, families and/or other health care professionals in emotionally charged s…

    Key features and assessment plan

    - This EPA focuses on the application of communication and conflict resolution skills to address difficult situations that involve patients, families, and/or members of the health care team in both the adult and pediatric setting. - This EPA may be observed in any scenario that is emotionally charged. Examples include: breaking bad news; disclosing an adverse event; difference of opinion with another care provider; dealing with a patient complaint.

    Direct observation by supervisor Use Form 1. Form collects information on: - Scenario: patient/family; other health care professional(s) - Setting: clinical; simulation Collect 3 observations of achievement - At least 1 with patient/family - At least 1 with other health care professional(s) - No more than 1 in simulation

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Scenario

    1. patient/family
    2. other health care professional(s)

    Setting

    1. clinical
    2. simulation

    Medical Expert

    • ME 2.1 Ascertain participants’ understanding of the situation and the reason for the encounter

    Communicator

    • COM 1.1 Demonstrate empathy, respect and compassion
    • COM 3.1 Provide information and explanations that are clear and accurate
    • COM 3.1 Verify understanding of information conveyed
    • COM 1.4 Identify, verify and validate non-verbal cues
    • COM 2.2 Manage the flow of the encounter
    • COM 1.5 Recognize when strong emotions (such as anger, fear, anxiety, or sadness) are impacting an interaction and respond appropriately
    • COM 1.5 Establish boundaries as needed in emotionally charged situations
    • COM 2.2 Summarize and close the encounter effectively
    • COM 5.1 Document the encounter to convey the discussion and its outcome

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-15

    Documenting consultation reports

    Key features and assessment plan

    - This EPA focuses on writing a good consultation note using any format: hand-written, dictated, electronic medical record. - This includes a synthesis of the pertinent clinical findings, investigations and management plan, as well as clear articulation of the role of the dermatologist and the referring physician in further care. It may include linking the recommendations to evidence-based guidelines or other educational references for the referring physician. - The documents submitted for review must be the sole work of the resident. - This EPA may be observed in any care setting and with any patient presentation.

    Review of clinical documentation by supervisor Use Form 1 Collect 5 observations of achievement - At least 2 different assessors

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Communicator

    • COM 5.1 Document all relevant findings and investigations
    • COM 5.1 Convey clinical reasoning and the rationale for decisions
    • COM 5.1 Provide a clear plan for ongoing management
    • COM 5.1 Complete clinical documentation in a timely manner

    Collaborator

    • COL 1.2 Identify the roles of the dermatologist and the referring physician in the ongoing management plan
    • COL 3.2 Provide anticipatory guidance for results of outstanding investigations and/or next steps for management

    Scholar

    • S 1.3 Provide teaching points to improve quality of care

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-16

    Providing dermatologic care using virtual health technology

    Key features and assessment plan

    - This EPA focuses on providing dermatologic care to patients with poor access to direct patient visits, using technology such as telederm, telehealth, and other emerging virtual health technologies. - This includes patients with any diagnosis, seen for initial assessment or for follow-up. - This includes evaluating the amount and quality of information that can be gathered via the virtual assessment and determining whether an in-person assessment is required. - It also includes considerations of professionalism and patient privacy in the use of medical technology.

    Direct observation or case review by supervisor or TTP resident Use Form 1. Form collects information on: - Observation: direct; case review - Demographic: adult; pediatric - Visit: new; follow-up - Presentation (write in): Collect 3 observations of achievement - At least 1 direct observation - At least 2 new visits - At least 2 different assessors

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Observation

    1. direct
    2. case review

    Demographic

    1. adult
    2. pediatric

    Visit

    1. new
    2. follow-up

    Medical Expert

    • ME 2.2 Gather a relevant clinical history
    • ME 2.2 Perform a physical examination adapted to the virtual health environment
    • ME 2.2 Review photographs or images of the skin condition
    • ME 2.2 Select and/or interpret investigations
    • ME 2.2 Assess the quality of the clinical information gathered
    • ME 2.4 Determine if an in-person visit is required
    • ME 2.4 Develop a management plan

    Communicator

    • COM 5.3 Use virtual health technology in a manner that respects patient privacy and confidentiality
    • COM 2.3 Seek and synthesize relevant information from other sources (e.g. family, medical record)
    • COM 3.1 Convey information to the patient related to any uncertainty in diagnosis and/or treatment
    • COM 5.2 Communicate effectively with the patient in the virtual health environment

    Leader

    • L 2.1 Apply knowledge of the health care resources available in other care settings

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-17

    Interpreting skin histopathology for the purposes of diagnosis and management

    Key features and assessment plan

    - This EPA focuses on using the microscope to assess samples of the skin and specialized structures. It includes photomicrographs. - This includes identification of salient features and common reaction patterns, and development of a differential and most likely diagnosis. - This EPA may include, but does not require, preparation of a pathology report.

    Direct observation and/or case or photomicrograph review by dermatologist, pathologist, TTP pathology resident, or dermatopathology fellow Use Form 1. Form collects information on: - Diagnosis: inflammatory; infection; neoplastic; other Collect 6 observations of achievement - At least 2 inflammatory - At least 2 infectious - At least 2 neoplastic

    Suggested observations: 6

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Diagnosis

    1. inflammatory
    2. infection
    3. neoplastic
    4. other

    Medical Expert

    • ME 2.2 Assess the quality of the sample and any impact on the diagnostic interpretation
    • ME 1.3 Apply knowledge of dermatopathology and immunodermatopathology
    • ME 2.2 Identify salient features in the tissue sample
    • ME 3.1 Recognize when a specimen might require ancillary studies
    • ME 2.2 Select ancillary investigations and techniques such as special stains and polarized light
    • ME 2.2 Correlate findings with clinical information and results of other investigations
    • ME 2.2 Establish a diagnosis or differential diagnosis

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-18

    Delivering scholarly teaching to peers, junior trainees and/or other health professionals

    Key features and assessment plan

    - This EPA focuses on the skills of critical appraisal as well as presentation and teaching skills. - This includes formal (didactic) teaching sessions, such as grand rounds, academic half-day presentations, journal club. - It also includes informal teaching, such as clinical rounds (i.e. patient reviews), case presentations or in-clinic/bedside teaching.

    Direct observation by supervisor Use Form 1. Form collects information on: - Teaching activity: formal; informal Collect 5 observations of achievement - At least 3 observations of formal teaching - At least 2 observations of informal teaching

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Teaching activity

    1. formal
    2. informal

    Scholar

    • S 2.4 Identify the learning needs and desired learning outcomes of others
    • S 2.4 Develop learning objectives for a teaching activity
    • S 3.3 Critically evaluate the literature
    • S 3.4 Integrate best evidence and clinical expertise
    • S 2.2 Create a positive learning environment
    • S 2.4 Present the information in an organized manner to facilitate understanding
    • S 2.4 Use audiovisual aids effectively
    • S 2.4 Provide adequate time for questions and discussion
    • S 2.4 Facilitate learner engagement and participation

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • C-19

    Conducting scholarly work relevant to Dermatology

    Key features and assessment plan

    - This EPA includes all aspects of performing scholarly work: identification of a question for investigation, literature review, data gathering, data analysis, reflective critique and dissemination. - This may include scholarly research, quality improvement, or educational work relevant to Dermatology that is suitable for peer review publication or presentation at an academic meeting. - Assessment is based on the submission of a completed scholarly project, and/or observation of the presentation of the scholarly work at a local, national or international meeting.

    Review of submitted manuscript and/or direct observation of presentation by research supervisor, program director and/or another faculty member (e.g. research director) within the dermatology division/department Use Form 4 Collect 1 observation of achievement

    Suggested observations: 1

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Scholar

    • S 4.4 Generate focused questions for scholarly investigation
    • S 3.3 Critically evaluate the literature
    • S 4.5 Summarize the findings of a literature review
    • S 4.4 Select appropriate methods of addressing a given scholarly question
    • S 4.2 Identify ethical principles in research
    • S 4.4 Collect data for a scholarly project
    • S 4.4 Perform data analysis
    • S 4.4 Interpret and integrate data in context of existing literature
    • S 4.5 Disseminate the findings of scholarly activity, in written or oral form

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

Transition to Practice

  • TTP-1

    Managing a dermatology consultation service

    Key features and assessment plan

    - This EPA includes all aspects of leading an inpatient consultation service, including responsibility for medical care decisions, incoming consultations, appropriate follow- up and handover, collaboration with other health care professionals and communication with the patient and family. - This may include organizing the dermatology team: organizing the workload, delegating tasks, and supervising other residents/students. - The observation of this EPA is based on a period of at least one week of consultation service during which the resident is providing day time as well as some evening/overnight coverage.

    Direct and/or indirect observation by supervisor Use Form 1 Collect 3 observations of achievement covering 3 separate weeks - 2 different assessors

    Suggested observations: 3

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.1 Demonstrate responsibility and accountability for patient care within the boundaries and expectations of the consultant role
    • ME 1.6 Prioritize patients based on the urgency of the clinical issue
    • ME 2.4 Establish management plans that consider all relevant aspects of the patient’s care

    Collaborator

    • COL 3.2 Provide safe handover of care
    • COL 1.3 Communicate effectively with the consulting service
    • COL 2.2 Work effectively with other health care professionals when there are differences in opinion and/or recommendations

    Leader

    • L 4.1 Manage time and prioritize tasks
    • L 4.1 Integrate supervisory and teaching responsibilities into the overall management of the clinical service

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Professional

    • P 1.1 Behave in a professional manner

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • TTP-2

    Managing patients with dermatologic conditions in the outpatient setting

    Key features and assessment plan

    - This EPA integrates the resident’s medical decision-making abilities for individual cases with their abilities to function effectively in the outpatient setting; managing a clinic load of patients, making appropriate clinical decisions, staying on time and working effectively with other health professionals. - This EPA may be observed in any outpatient clinic setting, with any patient mix. - The observation of this EPA is based on at least a half-day or full day of clinic.

    Direct observation and/or case review with supervisor at end of a clinic day/half-day Use Form 1. Form collects information: - Setting: community; academic - Specialized clinic: no; yes Collect 5 observations of achievement - At least 3 different assessors

    Suggested observations: 5

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.3 Apply a broad base and depth of knowledge to the clinical management of patient presentations in Dermatology
    • ME 2.4 Establish management plans that consider all relevant aspects of the patient’s care
    • ME 4.1 Determine appropriate timing of future visits based on planned investigations, clinical status and/or anticipated clinical course

    Communicator

    • COM 5.1 Document clinical encounters in an accurate, complete, and timely manner

    Collaborator

    • COL 1.2 Work effectively with outpatient clinic staff

    Leader

    • L 4.1 Manage time effectively to maintain clinic flow

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • TTP-3

    Managing patients in a longitudinal clinic

    Key features and assessment plan

    - This EPA focuses on the longitudinal management of a group of patients in the role of the physician most responsible for patient care, i.e. in a continuity clinic. - This includes responsibility for medical care decisions and follow-up on investigations, providing all relevant aspects of care at and between patient visits, appropriate accessibility in between clinic visits and arranging for coverage by another physician while away. - It also includes completing medical documentation in a timely manner, and completing administrative responsibilities which may include billing, triaging, insurance forms, and phone calls. - The observation of this EPA is not based on a single patient encounter or clinic, but rather on the resident performance over a period of time. - Documentation of observations should begin in the Core stage, and must be achieved by the end of Transition to Practice.

    Direct observation, case review and/or chart audit by supervisor(s), which may include input from other faculty members, nurse, clerk +/- other health care professionals Use Form 3 Collect at least 2 observations at 2-3 month intervals.

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Medical Expert

    • ME 1.1 Demonstrate responsibility and accountability for decisions regarding patient care, acting in the role of most responsible physician
    • ME 1.6 Triage consultation requests based on clinical acuity
    • ME 2.4 Establish management plans that consider all relevant aspects of the patient’s care

    Communicator

    • COM 5.1 Document clinical encounters in an accurate, complete, and timely manner

    Collaborator

    • COL 1.2 Work effectively with outpatient clinic staff

    Leader

    • L 4.2 Manage bookings to optimize clinic scheduling
    • L 4.1 Manage time effectively to maintain clinic flow
    • L 4.1 Review and act on results of investigations in a timely manner

    Scholar

    • S 3.4 Integrate best evidence and clinical expertise into decision-making

    Professional

    • P 1.1 Respond punctually to requests from patients or other health care professionals
    • P 1.1 Make arrangements for coverage by another physician when absent or unavailable

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.

  • TTP-4

    Developing a plan for continuing professional development

    Key features and assessment plan

    - This EPA focuses on reviewing personal performance data (i.e. feedback and observations) to facilitate self-reflection, identify areas of personal strength as well as areas for improvement, and develop the skills that are required for continuing professional development. - This includes developing plans to address areas for improvement and/or gaps in knowledge, and may include additional areas of interest and future career goals. - The plan should be SMART (specific, measurable, achievable, relevant, and timely), and must include the appropriate choice of clinical experiences and/or appropriate academic resources (journals, textbooks, conferences).

    Review of resident’s submitted learning plan by supervisor, mentor, academic advisor or equivalent Use Form 4 Collect 1 observation of achievement

    Suggested observations: 1

    Entrustment (how much supervision did this activity need?)

    1. I had to do
    2. I had to talk them through
    3. I needed to prompt
    4. I needed to be there just in case
    5. I didn’t need to be there

    Leader

    • L 4.2 Examine personal interests and career goals
    • L 4.2 Adjust educational experiences to gain competencies necessary for future practice

    Scholar

    • S 1.2 Interpret data on personal performance to identify opportunities for learning and improvement
    • S 1.1 Define learning needs related to personal practice and/or career goals
    • S 1.1 Create a learning plan that is feasible, includes clear deliverables, timelines and a plan for monitoring ongoing achievement
    • S 1.1 Identify resources required to implement a personal learning plan

    Professional

    • P 2.1 Demonstrate a commitment to maintaining and enhancing competence

    Case description

    Feedback provided

    Next steps

    Copyright © 2021 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.